High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept
about
Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?Ubiquitous LEA29Y Expression Blocks T Cell Co-Stimulation but Permits Sexual Reproduction in Genetically Modified PigsCTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.Braking bad: novel mechanisms of CTLA-4 inhibition of T cell responses.New insights into T-cell cosignaling in allograft rejection and survival.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.Memory T cells in organ transplantation: progress and challenges.T Cell Cosignaling Molecules in Transplantation.Should belatacept be the centrepiece of renal transplantation?Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties.Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.Glutamate Receptor Interacting Protein 1 Regulates CD4(+) CTLA-4 Expression and Transplant Rejection.CD4+ CD28-Negative Cells: Armed and Dangerous.Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation.The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation.Human FOXP3+ T regulatory cell heterogeneity.Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade.
P2860
Q26796099-50960BF6-5F2D-4981-BB5F-AE61D88AF5C2Q27346701-12A6911A-3FBE-4EF6-A6CD-54046391593DQ33631095-1BF1CA65-052F-4E81-9177-E9AFF68043EFQ37164579-CD25E4A9-7FDB-45F1-B8FC-155F882F48B8Q38267186-3E963F65-A47B-42A0-A4F0-6AA58E03F9EBQ38309285-0E45D2AF-3A6B-45C1-BFAA-E509AD828D4DQ38681685-82F56213-88F3-4965-B93B-14E9D02A65D2Q38753494-EC23DCDF-90F0-4041-B271-5F34B9E97876Q38837473-8146E3CA-49C6-4764-B259-1D6D0CC4B217Q38862002-844A6517-F234-4969-BC64-9420F6655B53Q39289084-2E08EFD0-02C5-44A9-B5A9-5AF80175E0FEQ39782306-1770692A-417F-436B-820C-7C1B0E9E1DA0Q40198753-3EBA064F-8BB4-4F44-92C8-0EDCFA0B8FDCQ40280785-5D11A9A1-D810-480B-A21A-017F5EB1770AQ42393633-C7CD9CBC-FDA9-4051-BF4B-CE670E86ED31Q42725698-2C8A2FD1-DBE8-4268-A426-40534D26B350Q44770974-9DF42FFB-345F-431C-ABEC-0EB2364B8218Q50320411-3EC0C962-7B97-4AA1-830B-DB731F37E591Q50993283-E4D61452-7322-4688-B536-ADBBA15D703DQ51742567-634405EB-C6E6-4D5B-A34A-FB464823DC3E
P2860
High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@ast
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@en
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@nl
type
label
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@ast
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@en
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@nl
prefLabel
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@ast
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@en
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@nl
P2093
P2860
P356
P1476
High CTLA-4 expression on Th17 ...... n and resistance to belatacept
@en
P2093
C P Larsen
J A Cheeseman
J A Conger
S M Krummey
P2860
P304
P356
10.1111/AJT.12600
P407
P577
2014-03-01T00:00:00Z